Published in Clin Exp Immunol on November 01, 1990
Biological significance of soluble IL-2 receptor. Mediators Inflamm (1993) 1.33
Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders. J Gastroenterol (1997) 0.80
High serum levels of CD8 antigen in primary biliary cirrhosis: a possible cause of suppressor cell dysfunction? Clin Exp Immunol (1991) 0.79
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Soluble interleukin 2 receptors are released from activated human lymphoid cells in vitro. J Immunol (1985) 5.70
Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients. Gut (1983) 2.53
Factors affecting mortality in biliary tract surgery. Am J Surg (1981) 2.41
Immunoglobulins in chronic liver disease. Gut (1968) 2.39
The released interleukin 2 receptor binds interleukin 2 efficiently. J Immunol (1986) 2.08
Prediction of risk in biliary surgery. Br J Surg (1983) 2.07
Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol (1989) 1.72
Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-1 and IL-2 inhibition. J Immunol (1988) 1.70
Soluble interleukin-2 receptors in systemic lupus erythematosus. Arthritis Rheum (1988) 1.67
Inhibition of PHA-stimulated lymphocyte transformation by plasma from patients with advanced alcoholic cirrhosis. Clin Exp Immunol (1971) 1.60
Interleukins and the immune system 1. Lancet (1989) 1.51
High interleukin-6 serum levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokines production. Clin Exp Immunol (1989) 1.50
Serum levels of soluble interleukin-2 receptors in acute and chronic viral hepatitis. Dig Dis Sci (1989) 1.47
Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg (1984) 1.43
Peripheral blood lymphocyte populations in chronic liver disease. Clin Exp Immunol (1976) 1.43
Plasma interleukin 2 receptor levels in renal allograft recipients. Clin Immunol Immunopathol (1987) 1.38
Soluble CD8 during T cell activation. J Immunol (1989) 1.34
The half-life of I131 labeled normal human gamma globulin in patients with hepatic cirrhosis. J Immunol (1954) 1.28
Lymphocyte transformation by phytohaemagglutinin (PHA) and purified protein derivative (PPD) in primary biliary cirrhosis. Evidence of serum inhibitory factors. Clin Exp Immunol (1973) 1.25
In vitro and in vivo studies of cellular immunity in alcoholic cirrhosis. Am J Dig Dis (1974) 1.24
Molecular interactions, T-cell subsets and a role of the CD4/CD8:p56lck complex in human T-cell activation. Immunol Rev (1989) 1.23
Biliary obstruction and host defense failure. J Surg Res (1982) 1.23
Serum immunoglobulin concentrations in patients with alcoholic liver disease. Gastroenterology (1969) 1.11
Soluble IL-2 receptor levels in serum from blood donors seropositive for HIV. J Immunol (1988) 1.03
Impaired specific cell-mediated immunity in experimental biliary obstruction and its reversibility by internal biliary drainage. J Surg Res (1986) 1.03
Soluble interleukin 2 receptors are released from the cell surface of normal murine B lymphocytes stimulated with interleukin 5. Proc Natl Acad Sci U S A (1988) 0.99
Liver disease--a prominent cause of serum IgE elevation. Clin Exp Immunol (1976) 0.98
Tumor necrosis factor alpha production by peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology (1989) 0.98
Sepsis in the management of complicated biliary disorders. Am J Surg (1979) 0.97
Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases. Clin Immunol Immunopathol (1989) 0.95
Serum immunoglobulins and organ non-specific antibodies in diseases of the liver. Scand J Gastroenterol (1977) 0.95
The malignant B cells from B-chronic lymphocytic leukemia patients release TAC-soluble interleukin-2 receptors. Blood (1988) 0.91
Soluble interleukin-2 receptors in serum and bile of liver transplant recipients. Lancet (1989) 0.91
Increase of serum interleukin 2 receptor level in thermally injured patients. Clin Immunol Immunopathol (1989) 0.90
Serum immunoglobulin A changes in alcoholic patients. Ann Clin Res (1977) 0.89
Deficient natural killer cell activity in alcoholic cirrhosis. Clin Exp Immunol (1984) 0.89
Impaired immune function in obstructive jaundice. J Surg Res (1988) 0.88
Decreased natural killer activity in patients with liver cirrhosis. Int J Cancer (1983) 0.85
Immune status in mice with experimental biliary obstruction. Clin Immunol Immunopathol (1980) 0.83
Increased levels of soluble CD8 molecule in the serum of patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related disorders. Clin Immunol Immunopathol (1989) 0.82
Decreased interleukin 1 activity in culture supernatant of lipopolysaccharide stimulated monocytes from patients with liver cirrhosis and hepatocellular carcinoma. Clin Exp Immunol (1987) 0.82
Interleukin 1 activity in culture supernatant of lipopolysaccharide-stimulated monocytes from patients with chronic liver disease. Hepatogastroenterology (1984) 0.81
T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions. Cell Immunol (1986) 0.81
Profound suppression of lymphocyte function in early biliary obstruction. Am J Med Sci (1988) 0.80
A FORTRAN program to perform the nonparametric Terpstra-Jonckheere test. Comput Programs Biomed (1984) 0.77
Effect of biliary obstruction on skin allograft survival in mice. Transplantation (1969) 0.76
Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet (2000) 4.83
Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin. Proc Natl Acad Sci U S A (1999) 4.55
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer. N Engl J Med (1989) 3.03
[Endoscopic sphincterotomy of the papilla of vater and extraction of stones from the choledochal duct (author's transl)]. Dtsch Med Wochenschr (1974) 3.03
Oral treatments for fungal infections of the skin of the foot. Cochrane Database Syst Rev (2002) 2.75
Complications of diagnostic gastrointestinal endoscopy. Endoscopy (1990) 2.69
Biopsy surveillance is still necessary in patients with Barrett's oesophagus despite new endoscopic imaging techniques. Gut (2003) 2.49
Size and albedo of Kuiper belt object 55636 from a stellar occultation. Nature (2010) 2.49
Pancreatography in chronic pancreatitis: international definitions. Gut (1984) 2.37
Current status of screening colonoscopy in Europe and in the United States. Endoscopy (2007) 2.14
A major fraction of human intraepithelial lymphocytes simultaneously expresses the gamma/delta T cell receptor, the CD8 accessory molecule and preferentially uses the V delta 1 gene segment. Eur J Immunol (1991) 2.06
[Prospective Epidemiologic Study of Epigastric Discomfort (PRESTO). Ground work and preliminary results]. Dtsch Med Wochenschr (1999) 2.01
The chemotherapeutic oxaliplatin alters voltage-gated Na(+) channel kinetics on rat sensory neurons. Eur J Pharmacol (2000) 1.91
Stulberg classification system for evaluation of Legg-Calvé-Perthes disease: intra-rater and inter-rater reliability. J Bone Joint Surg Am (1999) 1.85
Race and survival from breast cancer: based on Cancer and Leukemia Group B trial 8541. Cancer J Sci Am (1997) 1.79
The relationship between maternal and umbilical cord androgen levels and polycystic ovary syndrome in adolescence: a prospective cohort study. J Clin Endocrinol Metab (2009) 1.77
Staging of pancreatic and ampullary carcinoma by endoscopic ultrasonography. Comparison with conventional sonography, computed tomography, and angiography. Gastroenterology (1992) 1.68
Key importance of the Helicobacter pylori adherence factor blood group antigen binding adhesin during chronic gastric inflammation. Cancer Res (2001) 1.67
Percutaneous cholangioscopic or transpapillary insertion of self-expanding biliary metal stents. Gastrointest Endosc (1991) 1.61
Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial. Arch Fam Med (1998) 1.59
Complications and protocol considerations in carbon monoxide-poisoned patients who require hyperbaric oxygen therapy: report from a ten-year experience. Ann Emerg Med (1989) 1.55
Fibreendoscopy of the intestines. Gut (1971) 1.55
Guanylin strongly stimulates rat duodenal HCO3- secretion: proposed mechanism and comparison with other secretagogues. Gastroenterology (1996) 1.53
Potential utility of rubidium 82 PET quantification in patients with 3-vessel coronary artery disease. J Nucl Cardiol (2004) 1.53
Endoscopic ultrasound in pancreatic tumor diagnosis. Gastrointest Endosc (1991) 1.52
Aerobilia and hypomotility of the sphincter of Oddi in a patient with chronic intestinal pseudo-obstruction. Gastroenterology (1992) 1.46
[Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management]. Z Gastroenterol (2011) 1.46
Functional characterization of the Bcl-2 gene family in the zebrafish. Cell Death Differ (2006) 1.43
Extracts from "Clinical evidence": Athlete's foot and fungally infected toenails. BMJ (2001) 1.41
Performance, patient acceptance, appropriateness of indications and potential influence on outcome of EUS: a prospective study in 397 consecutive patients. Gastrointest Endosc (1999) 1.40
[Pyrimethamine-sulfadiazine resistant cerebral toxoplasmosis in AIDS]. Dtsch Med Wochenschr (1995) 1.39
[Minimal invasive therapy of gallstones by laparoscopic cholecystostomy]. Dtsch Med Wochenschr (1996) 1.39
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2007) 1.33
[Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study]. Dtsch Med Wochenschr (1985) 1.31
Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol (2001) 1.28
Endosonographic diagnosis of submucosal upper gastrointestinal tract tumors. Scand J Gastroenterol (1992) 1.28
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. Am Heart J (2006) 1.24
Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2005) 1.24
Gastrin secretion from primary cultures of rabbit antral G cells: stimulation by inflammatory cytokines. Gastroenterology (1996) 1.23
You get what you expect? A critical appraisal of imaging methodology in endosonographic cancer staging. Gut (2002) 1.21
Duodenitis. Significance and frequency. Bibl Gastroenterol (1970) 1.21
[Effect of prostaglandin E 1 on the basal gastric secretion in man]. Klin Wochenschr (1970) 1.20
Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. J Clin Oncol (2001) 1.18
Laser versus laser plus afterloading with iridium-192 in the palliative treatment of malignant stenosis of the esophagus: a prospective, randomized, and controlled study. Gastrointest Endosc (1991) 1.16
Squamous-cell carcinoma of the duodenum as a rare cause of upper gastrointestinal bleeding. Endoscopy (2006) 1.16
Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Database Syst Rev (2000) 1.16
Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure. Am J Cardiol (1977) 1.16
Capecitabine plus docetaxel every 3 weeks in first- and second-line metastatic oesophageal cancer: final results of a phase II trial. Br J Cancer (2005) 1.15
Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer. Br J Cancer (2012) 1.15
The quality of gastroenterological reports based on free text dictation: an evaluation in endoscopy and ultrasonography. Endoscopy (1991) 1.14
Evaluation of submucosal upper gastrointestinal tract lesions by endoscopic ultrasound. Gastrointest Endosc (1991) 1.12
Autoimmune progesterone dermatitis. Arch Dermatol (1977) 1.12
Wrapping things up: a qualitative analysis of the closing moments of the medical visit. Patient Educ Couns (1997) 1.11
The effects of 75 mg HOE 760, a novel H2-receptor antagonist, on daytime peptone-stimulated and nocturnal gastric acid output in healthy volunteers. Scand J Gastroenterol (1987) 1.10
Endoscopic laser lithotripsy with an automatic stone recognition system for basket impaction in the common bile duct. Endoscopy (1992) 1.09
Endoscopic papillotomy and removal of gall stones. Br Med J (1975) 1.09
Prospective evaluation of the use of endoscopic retrograde cholangiography prior to laparoscopic cholecystectomy. Endoscopy (1992) 1.08
Recessive multiple epiphyseal dysplasia (rMED): phenotype delineation in eighteen homozygotes for DTDST mutation R279W. J Med Genet (2003) 1.07
Portal hypertension caused by partial nodular transformation of the liver. Gut (1970) 1.06
Non-surgical removal of common bile duct stones. Gut (1977) 1.06
Randomized study of intracorporeal laser lithotripsy versus extracorporeal shock-wave lithotripsy for difficult bile duct stones. Gastrointest Endosc (1998) 1.05
Endoscopic ultrasound criteria for vascular invasion in the staging of cancer of the head of the pancreas: a blind reevaluation of videotapes. Gastrointest Endosc (2000) 1.05
[Endoscopic papillotomy and removal of gall-stones: animal experiments and first clinical results (author's transl)]. Dtsch Med Wochenschr (1974) 1.05
Functional impairment of rat enterochromaffin-like cells by interleukin 1 beta. Gastroenterology (1997) 1.04
Thallium-201 myocardial perfusion scintigraphy to evaluate patients after coronary bypass surgery. Am J Cardiol (1978) 1.04
Treatment of achalasia: botulinum toxin injection vs. pneumatic balloon dilation. A prospective study with long-term follow-Up. Endoscopy (2001) 1.03
Implantation of self-expanding esophageal metal stents for palliation of malignant dysphagia. Endoscopy (1992) 1.03
Pharmacokinetic and clinical phase II trial of imatinib in patients with impaired liver function and advanced hepatocellular carcinoma. Oncology (2005) 1.02
[Carbohydrate substitutes: comparative study of intestinal absorption of fructose, sorbitol and xylitol]. Med Klin (Munich) (1994) 1.01
Semen quality and cryopreservation in adolescent cancer patients. Hum Reprod (2002) 1.01
Upregulation of apoptosis with dietary restriction: implications for carcinogenesis and aging. Environ Health Perspect (1998) 1.01
Clinical, ultrasound and biochemical features of polycystic ovary syndrome in adolescents: implications for diagnosis. Hum Reprod (2011) 1.01
The effect of prostaglandin E 1 on the pentagastrin-stimulated gastric secretion in man. Digestion (1971) 1.01
Fatal outcome of lung transplantation in cystic fibrosis patients due to small-colony variants of the Burkholderia cepacia complex. Eur J Clin Microbiol Infect Dis (2003) 1.01
Long-term outcome in patients with advanced hilar bile duct tumors undergoing palliative endoscopic or percutaneous drainage. Z Gastroenterol (2000) 1.00
Operative endoscopy of the upper gastrointestinal tract. Gastrointest Endosc (1974) 1.00
Local staging and assessment of resectability in carcinoma of the esophagus, stomach, and duodenum by endoscopic ultrasonography. Gastrointest Endosc (1992) 0.99
Isolation, localization, and physical mapping of a highly polymorphic locus on human chromosome 11q13. Genomics (1991) 0.99
The role of diet and lifestyle measures in the pathogenesis and treatment of gastroesophageal reflux disease. Am J Gastroenterol (2000) 0.99
Glucose malabsorption associated with rapid intestinal transit. Am J Gastroenterol (1992) 0.98
Monoclonal antibody defines CA 19-9 in pancreatic juices and sera. Gut (1985) 0.98
Biomagnetic 3-dimensional spatial and temporal characterization of electrical activity of human stomach. Dig Dis Sci (1998) 0.98
Immunologic monitoring of heart transplant patients under cyclosporine immunosuppression. Transplant Proc (1984) 0.97
Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2. Eur J Pharmacol (1994) 0.96
Long-term results of percutaneous transhepatic biliary drainage for benign and malignant bile duct strictures. Scand J Gastroenterol (1998) 0.96
Cohort studies of health effects among people exposed to estuarine waters: North Carolina, Virginia, and Maryland. Environ Health Perspect (2001) 0.96
Laser lithotripsy of difficult bile duct stones under direct visual control. Gut (1993) 0.96
Ultrasonic tomography by means of an ultrasonic fiberendoscope. Endoscopy (1980) 0.95
Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database Syst Rev (2000) 0.95
Treatment of deep cartilage defects of the knee using autologous chondrograft transplantation and by abrasive techniques--a randomized controlled study. Acta Chir Belg (2005) 0.95
Gastric fundus impression caused by splenic vessels: detection by endoscopic ultrasound. Endoscopy (1991) 0.94
Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: a prospective study with long-term follow-up. Gastrointest Endosc (2001) 0.94
IL-1beta-induced apoptosis in rat gastric enterochromaffin-like cells is mediated by iNOS, NF-kappaB, and Bax protein. Gastroenterology (2000) 0.94
Treatment of esophagorespiratory fistulas with silicone-coated self-expanding metal stents. Gastrointest Endosc (1995) 0.94
Factor XIII substitution in ulcerative colitis. Lancet (1995) 0.94
Some properties of mucus in patients with gastric ulcer. Effect of treatment with carbenoxolone sodium. Scand J Gastroenterol (1972) 0.94
[Prevention of oxaliplatin-induced neuropathy by carbamazepine. A pilot study]. Dtsch Med Wochenschr (2002) 0.93